These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 12016484

  • 1. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
    Miyauchi A, Matsuzuka F, Hirai K, Yokozawa T, Kobayashi K, Ito Y, Nakano K, Kuma K, Futami H, Yamaguchi K.
    World J Surg; 2002 Aug; 26(8):1023-8. PubMed ID: 12016484
    [Abstract] [Full Text] [Related]

  • 2. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
    Miyauchi A, Matsuzuka F, Hirai K, Yokozawa T, Kobayashi K, Kuma S, Kuma K, Futami H, Yamaguchi K.
    World J Surg; 2000 Nov; 24(11):1367-72. PubMed ID: 11038208
    [Abstract] [Full Text] [Related]

  • 3. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.
    Cancer; 2002 Jan 15; 94(2):323-30. PubMed ID: 11900218
    [Abstract] [Full Text] [Related]

  • 4. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.
    Kihara M, Miyauchi A, Yoshioka K, Oda H, Nakayama A, Sasai H, Yabuta T, Masuoka H, Higashiyama T, Fukushima M, Ito Y, Kobayashi K, Miya A.
    Auris Nasus Larynx; 2016 Oct 15; 43(5):551-5. PubMed ID: 26837867
    [Abstract] [Full Text] [Related]

  • 5. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia.
    Colombo-Benkmann M, Brämswig J, Höppner W, Gellner R, Hengst K, Böcker W, Senninger N.
    World J Surg; 2002 Oct 15; 26(10):1286-90. PubMed ID: 12205548
    [Abstract] [Full Text] [Related]

  • 6. Importance of early screening and prophylactic thyroidectomy in asymptomatic nonindex RET germline carriers.
    Ukkat J, Lorenz K, Hinze R, Thomusch O, Dralle H.
    World J Surg; 2001 Jun 15; 25(6):713-7. PubMed ID: 11376404
    [Abstract] [Full Text] [Related]

  • 7. [Somatic ret proto-oncogene mutations in sporadic C-cell carcinoma of the thyroid gland].
    Frilling A, Bockhorn M, Kalinin V, Liedke M, Kaun M, Broelsch CE.
    Chirurg; 1997 Aug 15; 68(8):789-93. PubMed ID: 9377989
    [Abstract] [Full Text] [Related]

  • 8. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F, Martino E, Romeo G, Pacini F.
    J Clin Endocrinol Metab; 1996 Apr 15; 81(4):1619-22. PubMed ID: 8636377
    [Abstract] [Full Text] [Related]

  • 9. Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution.
    Ito Y, Miyauchi A, Yabuta T, Fukushima M, Inoue H, Tomoda C, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F.
    World J Surg; 2009 Jan 15; 33(1):58-66. PubMed ID: 19005720
    [Abstract] [Full Text] [Related]

  • 10. Extent of Surgery for Medullary Thyroid Cancer and Prevalence of Occult Contralateral Foci.
    Mao YV, Hughes EG, Steinmetz D, Troob S, Kim J, Tseng CH, Fishbein GA, Sajed DP, Livhits MJ, Yeh MW, Lee D, Angell TE, Wu JX.
    JAMA Otolaryngol Head Neck Surg; 2024 Mar 01; 150(3):209-214. PubMed ID: 38270925
    [Abstract] [Full Text] [Related]

  • 11. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M.
    J Clin Endocrinol Metab; 2003 May 01; 88(5):2070-5. PubMed ID: 12727956
    [Abstract] [Full Text] [Related]

  • 12. Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC.
    Kitamura Y, Goodfellow PJ, Shimizu K, Nagahama M, Ito K, Kitagawa W, Akasu H, Takami H, Tanaka S, Wells SA.
    Oncogene; 1997 Jun 26; 14(25):3103-6. PubMed ID: 9223675
    [Abstract] [Full Text] [Related]

  • 13. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM, Brauckhoff M, Schlichting E, Helset K, Svartberg J, Brauckhoff K, Mæhle L, Engebretsen LF, Sigstad E, Grøholt KK, Akslen LA, Jørgensen LH, Varhaug JE, Bjøro T.
    Thyroid; 2016 Sep 26; 26(9):1225-38. PubMed ID: 27400880
    [Abstract] [Full Text] [Related]

  • 14. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M, Weinhüsel A, Niederle B, Haas OA.
    Int J Cancer; 1996 Aug 22; 69(4):312-6. PubMed ID: 8797874
    [Abstract] [Full Text] [Related]

  • 15. [Usefulness of RET proto-oncogene in the diagnosis of hereditary-type medullary carcinoma of the thyroid. Correlation with surgical findings].
    Carreño M, Girbés J, Malluguiza R, Serrano S, Matias-Guiu X, Tudela J, Alfayate R, Lagarda H.
    Acta Otorrinolaringol Esp; 2001 Aug 22; 52(1):57-63. PubMed ID: 11269881
    [Abstract] [Full Text] [Related]

  • 16. Ret-proto-oncogene analysis in medullary thyroid carcinoma.
    O'Keeffe DA, Hill AD, Sheahan K, Ryan F, Barton D, Fitzgerald RJ, McDermott EW, O'Higgins NJ.
    Ir J Med Sci; 1998 Aug 22; 167(4):226-30. PubMed ID: 9868860
    [Abstract] [Full Text] [Related]

  • 17. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma].
    Wohllk N, Becker P, Youlton R, Cote GJ, Gagel RF.
    Rev Med Chil; 2001 Jul 22; 129(7):713-8. PubMed ID: 11552438
    [Abstract] [Full Text] [Related]

  • 18. Single center experience in primary surgery for medullary thyroid carcinoma.
    Ukkat J, Gimm O, Brauckhoff M, Bilkenroth U, Dralle H.
    World J Surg; 2004 Dec 22; 28(12):1271-4. PubMed ID: 15517488
    [Abstract] [Full Text] [Related]

  • 19. Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?
    Hansen HS, Torring H, Godballe C, Jäger AC, Nielsen FC.
    Cancer; 2000 Aug 15; 89(4):863-7. PubMed ID: 10951350
    [Abstract] [Full Text] [Related]

  • 20. Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.
    Ruiz A, Antiñolo G, Fernández RM, Eng C, Marcos I, Borrego S.
    Clin Endocrinol (Oxf); 2001 Sep 15; 55(3):399-402. PubMed ID: 11589684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.